Silicon Valley / San Jose Business Journal -- Cadence Pharmaceuticals Inc. on Monday said it has acquired an option to buy Incline Therapeutics Inc.for up to $285 million.
Silicon Valley / San Jose Business Journal -- Cadence Pharmaceuticals Inc. on Monday said it has acquired an option to buy Incline Therapeutics Inc.for up to $285 million.